Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate

L.S. Knudsen; Mikkel Østergaard; B Baslund; E Narvestad; J Petersen; Hans Jørgen Nielsen; B.J. Ejbjerg; Marcin Szkudlarek; J.S. Johansen

doi:10.1080/03009740600904300

Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate

L.S. Knudsen, Mikkel Østergaard, B Baslund, E Narvestad, J Petersen, Hans Jørgen Nielsen, B.J. Ejbjerg, Marcin Szkudlarek, J.S. Johansen

28 Citationer (Scopus)

Abstract

No abstract available

Originalsprog	Engelsk
Tidsskrift	Scandinavian Journal of Rheumatology
Vol/bind	35
Udgave nummer	6
Sider (fra-til)	489-91
Antal sider	3
ISSN	0300-9742
DOI	https://doi.org/10.1080/03009740600904300
Status	Udgivet - 2006

Adgang til dokumentet

10.1080/03009740600904300

http://www.informaworld.com/smpp/content~content=a769780754~db=all~order=page

Citationsformater

Knudsen, L. S., Østergaard, M., Baslund, B., Narvestad, E., Petersen, J., Nielsen, H. J., Ejbjerg, B. J., Szkudlarek, M., & Johansen, J. S. (2006). Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Scandinavian Journal of Rheumatology, 35(6), 489-91. https://doi.org/10.1080/03009740600904300

Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. / Knudsen, L.S.; Østergaard, Mikkel; Baslund, B et al.
I: Scandinavian Journal of Rheumatology, Bind 35, Nr. 6, 2006, s. 489-91.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Knudsen, LS, Østergaard, M, Baslund, B, Narvestad, E, Petersen, J, Nielsen, HJ, Ejbjerg, BJ, Szkudlarek, M & Johansen, JS 2006, 'Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate', Scandinavian Journal of Rheumatology, bind 35, nr. 6, s. 489-91. https://doi.org/10.1080/03009740600904300

@article{d17fcd3cf91244edafa7fc1ed7126465,

title = "Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate",

abstract = "No abstract available",

author = "L.S. Knudsen and Mikkel {\O}stergaard and B Baslund and E Narvestad and J Petersen and Nielsen, {Hans J{\o}rgen} and B.J. Ejbjerg and Marcin Szkudlarek and J.S. Johansen",

year = "2006",

doi = "10.1080/03009740600904300",

language = "English",

volume = "35",

pages = "489--91",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Informa Healthcare",

number = "6",

}

TY - JOUR

T1 - Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate

AU - Knudsen, L.S.

AU - Østergaard, Mikkel

AU - Baslund, B

AU - Narvestad, E

AU - Petersen, J

AU - Nielsen, Hans Jørgen

AU - Ejbjerg, B.J.

AU - Szkudlarek, Marcin

AU - Johansen, J.S.

PY - 2006

Y1 - 2006

N2 - No abstract available

AB - No abstract available

U2 - 10.1080/03009740600904300

DO - 10.1080/03009740600904300

M3 - Journal article

SN - 0300-9742

VL - 35

SP - 489

EP - 491

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - 6

ER -